Literature DB >> 10548187

Prevention of secondary ischemic insults after severe head injury.

C S Robertson1, A B Valadka, H J Hannay, C F Contant, S P Gopinath, M Cormio, M Uzura, R G Grossman.   

Abstract

OBJECTIVE: The purpose of this study was to compare the effects of two acute-care management strategies on the frequency of jugular venous desaturation and refractory intracranial hypertension and on long-term neurologic outcome in patients with severe head injury.
DESIGN: Randomized clinical trial.
SETTING: Level I trauma hospital. PATIENTS: One hundred eighty-nine adults admitted in coma because of severe head injury.
INTERVENTIONS: Patients were assigned to either cerebral blood flow (CBF)-targeted or intracranial pressure (ICP)-targeted management protocols during randomly assigned time blocks. In the CBF-targeted protocol, cerebral perfusion pressure was kept at >70 mm Hg and PaCO2 was kept at approximately 35 torr (4.67 kPa). In the ICP-targeted protocol, cerebral perfusion pressure was kept at >50 mm Hg and hyperventilation to a PaCO2 of 25-30 torr (3.33-4.00 kPa) was used to treat intracranial hypertension.
MEASUREMENTS AND MAIN RESULTS: The CBF-targeted protocol reduced the frequency of jugular desaturation from 50.6% to 30% (p = .006). Even when the frequency of jugular desaturation was adjusted for all confounding factors that were significant, the risk of cerebral ischemia was 2.4-fold greater with the ICP-targeted protocol. Despite the reduction in secondary ischemic insults, there was no difference in neurologic outcome. Failure to alter long-term neurologic outcome was probably attributable to two major factors. A low jugular venous oxygen saturation was treated in both groups, minimizing the injury that occurred in the ICP-targeted group. The beneficial effects of the CBF-targeted protocol may have been offset by a five-fold increase in the frequency of adult respiratory distress syndrome.
CONCLUSIONS: Secondary ischemic insults caused by systemic factors after severe head injury can be prevented with a targeted management protocol. However, potential adverse effects of this management strategy may offset these beneficial effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548187     DOI: 10.1097/00003246-199910000-00002

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  119 in total

1.  Clinical studies in severe traumatic brain injury: a controversial issue.

Authors:  Per-Olof Grände; Silvana Naredi
Journal:  Intensive Care Med       Date:  2002-02-09       Impact factor: 17.440

2.  Brain tissue oxygen guided treatment supplementing ICP/CPP therapy after traumatic brain injury.

Authors:  J Meixensberger; M Jaeger; A Väth; J Dings; E Kunze; K Roosen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

Review 3.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Biomarkers in neurocritical care.

Authors:  W Taylor Kimberly
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 5.  Respiratory mechanics in brain injury: A review.

Authors:  Antonia Koutsoukou; Maria Katsiari; Stylianos E Orfanos; Anastasia Kotanidou; Maria Daganou; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Nikoletta Rovina
Journal:  World J Crit Care Med       Date:  2016-02-04

Review 6.  Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".

Authors:  Carl-Henrik Nordström
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

7.  Does intracranial pressure monitoring improve outcome after severe traumatic brain injury?

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

8.  Vasopressor use and effect on blood pressure after severe adult traumatic brain injury.

Authors:  Pimwan Sookplung; Arunotai Siriussawakul; Amin Malakouti; Deepak Sharma; Jin Wang; Michael J Souter; Randall M Chesnut; Monica S Vavilala
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

9.  Refractory intracranial hypertension and "second-tier" therapies in traumatic brain injury.

Authors:  Nino Stocchetti; Clelia Zanaboni; Angelo Colombo; Giuseppe Citerio; Luigi Beretta; Laura Ghisoni; Elisa Roncati Zanier; Katia Canavesi
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

Review 10.  Physiological monitoring of the severe traumatic brain injury patient in the intensive care unit.

Authors:  Peter Le Roux
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.